HEREDITARY ANGIOEDEMA
Clinical trials for HEREDITARY ANGIOEDEMA explained in plain language.
Never miss a new study
Get alerted when new HEREDITARY ANGIOEDEMA trials appear
Sign up with your email to follow new studies for HEREDITARY ANGIOEDEMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New RNA drug aims to stop painful swelling attacks in rare genetic disease
Disease control Recruiting nowThis study tests an experimental drug called ADX-324 in 90 adults with hereditary angioedema (HAE) types 1 or 2. The drug uses a technology called siRNA to lower a protein involved in swelling attacks. Participants receive either the drug or a placebo to see if it safely reduces …
Matched conditions: HEREDITARY ANGIOEDEMA
Phase: PHASE3 • Sponsor: ADARx Pharmaceuticals, Inc. • Aim: Disease control
Last updated May 26, 2026 11:23 UTC
-
New hope for kids with rare swelling disorder: early access drug available
Disease control AVAILABLEThis program provides early access to an investigational drug called sebetralstat for children aged 2 to 11 with hereditary angioedema (HAE). HAE causes sudden, painful swelling attacks. The drug is taken at the time of an attack to help control symptoms. The program is for child…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: KalVista Pharmaceuticals, Ltd. • Aim: Disease control
Last updated May 18, 2026 12:11 UTC
-
New registry aims to shed light on rare diseases
Knowledge-focused Recruiting nowThis study is creating a large database to collect information about people with rare diseases like amyloidosis, sarcoidosis, and many others. Researchers will track patients' health, treatments, and outcomes over time. The goal is to better understand these conditions and improv…
Matched conditions: HEREDITARY ANGIOEDEMA
Sponsor: Hospital Italiano de Buenos Aires • Aim: Knowledge-focused
Last updated May 26, 2026 11:17 UTC